Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2010; 3:204-211, doi:10.1016/j.jcmg.2009.09.021
© 2010 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindner, J. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lindner, J. R.

State-of-the-Art Paper

Molecular Imaging of Myocardial and Vascular Disorders With Ultrasound

Jonathan R. Lindner, MD*

Division of Cardiovascular Medicine, Oregon Health & Science University, Portland, Oregon

* Reprint requests and correspondence: Dr. Jonathan R. Lindner, Cardiovascular Division UHN-62, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239 (Email: lindnerj{at}ohsu.edu).

Methods for noninvasive imaging of specific disease-related molecular changes are being developed in order to expand and improve diagnostic capabilities and to enhance therapeutic decision making in the clinical setting. These new techniques have also started to be incorporated into research programs in order to better characterize pathophysiology or evaluate treatment efficacy. Molecular imaging with contrast-enhanced ultrasound relies on the detection of the acoustic signal produced by either microbubbles or other acoustically active particulate agents that are targeted to sites of disease. This review describes the progress that has been made in the development and testing of methods for contrast ultrasound molecular imaging of cardiovascular disease. Specifically, topics that will be addressed include: 1) the bioengineering and detection schemes for targeted probes; 2) specific disease processes (myocardial ischemia, atherosclerosis, and transplant rejection) where molecular imaging may play a role; and 3) the potential role of ultrasound as a molecular imaging technique.

Key Words: contrast ultrasound • microbubbles • molecular imaging

Abbreviations and Acronyms
  CEU = contrast-enhanced ultrasound
  ECAM = endothelial cell adhesion molecule
  ICAM-1 = intercellular adhesion molecule-1
  mAb = monoclonal antibody
  VCAM-1 = vascular cell adhesion molecule-1




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
N. M. Caplice and K. Martin
Contrast-Enhanced Ultrasound and the Enigma of Plaque Neovascularization
J. Am. Coll. Cardiol. Img., December 1, 2010; 3(12): 1273 - 1275.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
W. S. Kerwin
Noninvasive Imaging of Plaque Inflammation: Role of Contrast-Enhanced MRI
J. Am. Coll. Cardiol. Img., November 1, 2010; 3(11): 1136 - 1138.
[Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. H. Marwick and J. Narula
Contrast Echocardiography: Over-Achievement in Research, Under-Achievement in Practice?
J. Am. Coll. Cardiol. Img., February 1, 2010; 3(2): 224 - 225.
[Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link